Myasthenia gravis: open trials in Spain

21 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07463521
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Hospital General Universitario Dr. Balmis, Alicante · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Basurto, Bilbao · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario Infanta Sofia, San Sebastián de los Reyes · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-06
NCT07465289
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Hospital General Universitario Dr. Balmis, Alicante · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Basurto, Bilbao · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario Infanta Sofia, San Sebastián de los Reyes · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-06
NCT04951622
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital General Universitario Dr. Balmis, Alicante · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-05
NCT07323316
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Trial Treatment · Ad scientiam
Hospital Universitari de Bellvitge, Barcelona · Hospital Universitario Infanta Sofia, Madrid · Hospital Universitario La Paz, Madrid · Hospital de día de Neurología, Santiago de Compostela
Registry updated 2026-11-05
NCT07673627
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Trial Treatment · Phase 2 · argenx
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Regional de Málaga, Málaga
Registry updated 2026-11-04
NCT05374590
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT07217587
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Donostia, Donostia · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Infanta Sofia, San Sebastián de los Reyes · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT07647510
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario La Paz, Madrid
Registry updated 2026-10-30
NCT07294170
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Research · argenx
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Regional Universitario de Malaga - Hospital General, Málaga
Registry updated 2026-10-26
NCT06987539
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Trial Treatment · Phase 2 · Amgen
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-23
NCT06463587
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-21
2025-525127-27-00
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis
Trial Treatment · Phase 1/2 · Aurinia Pharmaceuticals Inc.
Hospital General Universitario Dr. Balmis, Alicante · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Donostia, Donostia · Hospital Universitario La Paz, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Infanta Sofia, San Sebastián de los Reyes · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-13
NCT06392386
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-28
NCT07284420
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Trial Treatment · Phase 2 · argenx
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Regional de Málaga, Málaga
Registry updated 2026-09-24
NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-08-21
NCT07039916
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Immunovant Sciences GmbH
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitari General de Catalunya, Sant Cugat del Vallès
Registry updated 2026-07-30
2023-507539-40-00
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-02-26
NCT06298565
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Research · argenx
Hospital Universitari de Bellvitge, Barcelona · Hospital Universitari Vall d'Hebron, Unitat de Malalties Neuromusculars, Servei de Neurologia, Barcelona · Hospital Clínico Universitario San Carlos, Madrid · Hospital Universitario Virgen Macarena, Seville
Registry updated 2026-02-17
NCT06299748
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Research · argenx
Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-02-17
NCT07250750
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
Trial Treatment · Phase 1/2 · ImmunAbs Inc.
Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Central De Asturias, Oviedo · Clínica Universidad de navarra, Pamplona
Registry updated 2026-02-11
2024-516015-24-00
Efficacy and tolerability of efgartigimod as early treatment in patients with generalized myasthenia gravis.
Trial Treatment · Phase 4 · Bellvitge University Hospital
Bellvitge University Hospital, L'hospitalet De Llobregat
Registry updated 2024-12-05

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error